A New and Unique Way to Measure Liver Function

Non-invasive tests made from natural compounds
Assesses the portal circulation
Estimates portal-systemic shunt
May detect disease in its earliest stages

Peer-Reviewed Scientific Articles

Below are peer-reviewed scientific articles, published in medical journals, that resulted from the QLFT Study of the HALT-C Trial and demonstrate the potential of research prototypes of HepQuant tests:

Quantitative Liver Function Tests Improve The Prediction of Clinical Outcomes in Chronic Hepatitis C: Results From The Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial. Hepatology. 55: 1019-1029.

Portal-systemic Shunting in Patients with Fibrosis or Cirrhosis due to Chronic Hepatitis C: the Minimal Model for Measuring Cholate Clearances and Shunt.

More recent data demonstrating the prognostic potential of research prototypes of HepQuant tests was presented at the AASLD Liver Meeting 2009:

Hepatic Impairment Measured by Quantitative Tests of Liver Function (QLFTs) Predicts Clinical Outcome in Patients with Advanced Fibrosis: Results from the HALT-C Trial

Current Types of Liver Diagnostic Tests:

Liver Panel
Biopsy
HVPG
Spleen Ultrasound
Endoscopy
Fibroscan (Investigational)
BreathID (Investigational)

Want more information?
Have Questions?

Contact HepQuant Now